CRISPR has the power to correct genetic mutations, but current delivery methods are either unsafe or inefficient, keeping the technology from reaching its full medical potential. With the power to ...

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

A top US regulator plans to unveil a faster approach to approving custom gene-editing treatments, a move designed to unleash a wave of industry investment that will yield cures for patients with rare ...

Traditional breeding and genetic modification methods have struggled to keep pace with the rapid evolution of plant viruses. CRISPR/Cas systems, originally derived from bacterial immune responses, ...

It cuts genomes, edits DNA, and holds the potential to treat a vast range of diseases. Now, CRISPR is being put to a new test as a search-and-detect engine for Covid-19. On Thursday, researchers at ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

The apparel industry accounts for 10% of greenhouse gas emissions. Biotechs are working on reengineering natural products to make more sustainable textiles, which are gaining traction.

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell. After that ...

"The very secrets of life — our DNA — is something that we can not only read these days, but we can write. We can rewrite it if we want to," Isaacson says. "It made me think that all of us should ...

Several ETFs focus on CRISPR gene editing, including ARKG and GNOM. ARKG owns shares in companies developing CRISPR therapies such as CRISPR Therapeutics. WDNA tracks companies transformed by genetics ...